The effects of cannabis use expectancies on self-initiated cannabis cessation

Addiction

Volumn 108, Issue 9, 2013, Pages 1649-1657

  Boden, Matthew Tyler ^a   Mckay, James R ^b,c   Long, W Robert ^d   Bonn Miller, Marcel O ^a,b,c  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Cannabis; Cannabis dependence; Cessation; Expectancies; Lapse; Marijuana; Relapse

Indexed keywords

CANNABIS;

ANTICIPATION; ARTICLE; CANNABIS ADDICTION; CESSATION; EXPECTANCIES; FEMALE; HUMAN; LAPSE; MALE; MIDDLE AGED; MOTIVATION; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RECURRENT DISEASE; RELAPSE; SELF CARE; SOLDIER; UNITED STATES; MARIJUANA ABUSE; PSYCHOLOGY;

CANNABIS; CANNABIS DEPENDENCE; CESSATION; EXPECTANCIES; LAPSE; MARIJUANA; RELAPSE;

ANTICIPATION, PSYCHOLOGICAL; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; MIDDLE AGED; MILITARY PERSONNEL; MOTIVATION; PROSPECTIVE STUDIES; QUESTIONNAIRES; RECURRENCE; SELF CARE; UNITED STATES;

EID: 84882241390     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.12233     Document Type: Article

References (61)

1. Substance Abuse and Mental Health Services Administration. Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-41. HHS Publication No. (SMA) 11-4658. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2011.
2. Bonn-Miller M. O., Harris A. H. S., Trafton J. A. Prevalence of cannabis use disorder diagnoses among veterans in 2002, 2008, and 2009. Psychol Serv 2012; 9: 404-416.
3. Copersino M. L., Boyd S. J., Tashkin D. P., Huestis M. A., Heishman S. J., Dermand J. C. etal. Cannabis withdrawal among non-treatment-seeking adult cannabis users. Am J Addict 2006; 15: 8-14.
4. Cunningham J. Remission from drug dependence: is treatment a prerequisite? Drug Alcohol Depend 2000; 59: 211-213.
5. Weiner M., Sussman S., McCuller W., Lichtman K. Factors in marijuana cessation among high-risk youth. J Drug Educ 1999; 29: 337-357.
6. Roffman R. A., Stephens R. S. Cannabis Dependence: Its Nature, Consequences, and Treatment. Cambridge, UK: Cambridge University Press; 2006.
7. Larimer M. E., Palmer R. S., Marlatt G. A. Relapse prevention: an overview of Marlatt's cognitive-behavioral model. Alcohol Res Health 1999; 23: 151-160.
8. Budney A. J., Radonovich K. J., Higgins S. T., Wong C. J. Adults seeking treatment for marijuana dependence: a comparison with cocaine-dependent treatment seekers. Exp Clin Psychopharmacol 1998; 6: 419-426.
9. Moore B. A., Budney A. J. Relapse in outpatient treatment for marijuana dependence. J Subst Abuse Treat 2003; 25: 85-89.
10. Stephens R. S., Roffman R. A., Simpson E. E. Adult marijuana users seeking treatment. J Consult Clin Psychol 1993; 61: 1100-1104.
11. Brown S. Reinforcement expectancies and alcoholism treatment outcome after a one-year follow-up. J Stud Alcohol 1985; 46: 304-308.
12. Conway K. P., Swendsen J. D., Merikangas K. R. Alcohol expectancies, alcohol consumption, and problem drinking: the moderating role of family history. Addict Behav 2003; 28: 823-836.
13. Cooper M. L., Russell M., Skinner J. B., Frone M. R., Mudar P. Stress and alcohol use: moderating effects of gender, coping, and alcohol expectancies. J Abnorm Psychol 1992; 101: 139-152.
14. Leventhal A. M., Schmitz J. M. The role of drug use outcome expectancies in substance abuse risk: an interactional-transformational model. Addict Behav 2006; 31: 2038-2062.
15. Jones B. T., Corbin W., Fromme K. A review of expectancy theory and alcohol consumption. Addiction 2001; 96: 57-72.
16. Leigh B. C., Stacy A. W. Alcohol outcome expectancies: scale construction and predictive utility in higher order confirmatory models. Psychol Assess 1993; 5: 216-229.
17. Aarons G. A., Brown S. A., Stice E., Coe M. T. Psychometric evaluation of the marijuana and stimulant effect expectancy questionnaires for adolescents. Addict Behav 2001; 26: 219-236.
18. Simons J. S., Arens A. M. Moderating effects of sensitivity to punishment and sensitivity to reward on associations between marijuana effect expectancies and use. Psychol Addict Behav 2007; 21: 409-414.
19. Buckner J. D., Schmidt N. B. Marijuana effect expectancies: relations to social anxiety and marijuana use problems. Addict Behav 2008; 33: 1477-1483.
20. Connor J. P., Gullo M. J., Feeney G. F., Young R. M. Validation of the Cannabis Expectancy Questionnaire (CEQ) in adult cannabis users in treatment. Drug Alcohol Depend 2011; 115: 167-174.
21. Hall S. M., Havassy B. E., Wasserman D. A. Commitment to abstinence and acute stress in relapse to alcohol, opiates, and nicotine. J Consult Clin Psychol 1990; 58: 175-181.
22. Marlatt G. A. Harm reduction: come as you are. Addict Behav 1996; 21: 779-788.
23. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Text revision. Washington, DC: American Psychiatric Association; 2000.
24. Budney A. J., Hughes J. R., Moore B. A., Vandrey R. Review of the validity and significance of cannabis withdrawal syndrome. Am J Psychiatry 2004; 161: 1967-1977.
25. First M. B., Spitzer R. L., Gibbon M., Williams J. B. W. Structured Clinical Interview for DSM-IV (SCID-I) (User's Guide and Interview) Research Version. New York: Biometrics Research Department, New York Psychiatric Institute; 1995.
26. Blake D. D., Weathers F. W., Nagy L. M., Kaloupek D. G., Gusman F. D., Charney D. S. etal. The development of a Clinician-Administered PTSD Scale. J Trauma Stress 1995; 8: 75-90.
27. Weathers F. W., Keane T. M., Davidson J. R. Clinician-administered PTSD scale: a review of the first ten years of research. Depress Anxiety 2001; 13: 132-156.
28. Sobell L., Sobell M. Timeline Follow-back: a technique for assessing self-reported ethanol consumption. In: Allen J., Litten R. Z., editors. Measuring Alcohol Consumption: Psychosocial and Biological Methods, Totowa, NJ: Humana Press; 1992, p. 41-72.
29. Budney A. J., Hughes J. R., Moore B. A., Novy P. L. Marijuana abstinence effects in marijuana smokers maintained in their home environment. Arch Gen Psychiatry 2001; 58: 917-924.
30. Hjorthøj C. R., Fohlmann A., Larsen A. M., Arendt M., Nordentoft M. Correlations and agreement between delta-9-tetrahydrocannabinol (THC) in blood plasma and timeline follow-back (TLFB)-assisted self-reported use of cannabis of patients with cannabis use disorder and psychotic illness attending CapOpus randomized clinical trial. Addiction 2012; 107: 1123-1131.
31. Sobell L. C., Sobell M. B. Alcohol abuse and smoking: dual recoveries. Alcohol Health Res World 1996; 20: 124-127.
32. Schafer J., Brown S. A. Marijuana and cocaine effect expectancies and drug use patterns. J Consult Clin Psychol 1991; 59: 558-565.
33. Brown R. A., Kahler C. W., Zvolensky M. J., Lejuez C. W., Ramsey S. E. Anxiety sensitivity: relationship to negative affect smoking and smoking cessation in smokers with past major depressive disorder. Addict Behav 2001; 26: 887-899.
34. Zvolensky M. J., Bernstein A., Cardenas S. J., Colota V. A., Marshall E. C., Feldner M. T. Anxiety sensitivity and early relapse to smoking: a test among Mexican daily, low-level smokers. Nicotine Tob Res 2007; 9: 483-491.
35. Zvolensky M. J., Bernstein A., Marshall E. C., Feldner M. T. Panic attacks, panic disorder, and agoraphobia: associations with substance use, abuse, and dependence. Curr Psychiatry Rep 2006; 8: 279-285.
36. Fournier D. A., Skaug H. J., Ancheta J., Ianelli J., Magnusson A., Maunder M. etal. AD model builder: using automatic differentiation for statistical inference of highly parameterized complex nonlinear models. Optim Methods Softw 2012; 27: 233-249.
37. R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2012.
38. Skaug H., Fournier D., Nielsen A., Magnusson A., Bolker B. Generalized linear mixed models using AD model builder. R package. Version 0.7.3; 2012.
39. Atkins D. C., Baldwin S. A., Zheng C., Gallop R. J., Neighbors C. A tutorial on count regression and zero-altered count models for longitudinal substance use data. Psychol Addict Behav 2013; 27: 166-177.
40. Hall D. B. Zero-inflated poisson and binomial regression with random effects: a case study. Biometrics 2000; 56: 1030-1039.
41. Miller G. A., Chapman J. P. Misunderstanding analysis of covariance. J Abnorm Psychol 2001; 110: 40-48.
42. Graham J. W. Missing Data: Analysis and Design. New York: Springer; 2012.
43. van Buuren S., Groothuis-Oudshoorn K. Mice: multivariate imputation by chained equations in R. J Stat Softw 2011; 45: 1-67.
44. D'Orazio M. Package 'StatMatch'. R package. Version 1.2.0; 2012.
45. Andridge R. R., Little R. J. A. A review of hot deck imputation for survey non-response. Int Stat Rev 2010; 78: 40-64.
46. Fuller W. A., Kim J. K. Hot deck imputation for the response model. Surv Methodol 2005; 31: 139-149.
47. Geweke J. Evaluating the accuracy of sampling-based approaches to calculating posterior moments. In: Bernardo J. M., Berger J. O., Dawiv A. P., Smith A. F. M., editors. Bayesian Statistics, vol. 4. Oxford, UK: Clarendon Press; 1992, p. 169-193.
48. Raudenbush S. W., Bryk A. S. Hierarchical Linear Models: Applications and Data Analysis Methods, 2nd edn. Newbury Park, CA: Sage; 2002.
49. Singer J. D., Willett J. B. Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence. New York: Oxford University Press; 2003.
50. Johnson K., Mullin J. L., Marshall E. C., Bonn-Miller M. O., Zvolensky M. Exploring the meditational role of coping motives for marijuana use in terms of the relation between anxiety sensitivity and marijuana dependence. Am J Addict 2010; 19: 277-282.
51. Simons J., Correia C. J., Carey K. B. A comparison of motives for marijuana and alcohol use among experienced users. Addict Behav 2002; 25: 153-160.
52. Simons J., Correia C. J., Carey K. B., Borsari B. E. Validating a five-factor marijuana motives measure: relations with use, problems, and alcohol motives. J Couns Psychol 1998; 45: 265-273.
53. Raichlen D. A., Foster A. D., Gerdeman G. L., Seillier A., Giuffrida A. Wired to run: exercise-induced endocannabinoid signaling in humans and cursorial mammals with implications for the 'runner's high'. J Exp Biol 2012; 215: 1331-1336.
54. Sparling P. B., Giuffrida A., Piomelli D., Rosskopf L., Dietrich A. Exercise activates the endocannabinoid system. Neuroreport 2003; 14: 2209-2211.
55. Hughes J. R., Peters E. N., Callas P. W., Budney A. J., Livingstone A. E. Attempts to stop or reduce marijuana use in non-treatment seekers. Drug Alcohol Depen 2008; 97: 180-184.
56. Darkes J., Goldman M. S. Expectancy challenge and drinking reduction: experimental evidence for a mediational process. J Consult Clin Psychol 1993; 61: 344-353.
57. Kivlahan D. R., Marlatt G. A., Fromme K., Coppel D. B., Williams E. Secondary prevention with college drinkers: evaluation of an alcohol skills training program. J Consult Clin Psychol 1990; 58: 805-810.
58. Fromme K., Stroot E. A., Kaplan D. Comprehensive effects of alcohol: development and psychometric assessment of a new expectancy questionnaire. Psychol Assess 1993; 5: 19-26.
59. Ham L. S., Stewart S. H., Norton P. J., Hope D. A. Psychometric assessment of the comprehensive effects of alcohol questionnaire: comparing a brief version to the original full scale. J Psychopathol Behav 2005; 27: 141-158.
60. Hayakawa K., Mishima K., Nozako M., Ogata A., Hazekawa M., Liu A. X. etal. Repeated treatment with cannabidiol but not Delta9-tetrahydrocannabinol has a neuroprotective effect without the development of tolerance. Neuropharmacology 2007; 52: 1079-1087.
61. Tambaro S., Bortolato M. Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives. Recent Pat CNS Drug Discov 2012; 7: 25-40.